XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.3
STATEMENTS OF CONSOLIDATED CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income [1] $ 84.3 $ 45.9 [2],[3]
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation of property, plant and equipment [1] 88.2 83.4 [4]
Amortization of definite-lived intangible assets [1] 3.4 3.4 [4]
Amortization of debt premium and debt issuance costs [1] 1.7 1.8 [4]
Deferred income taxes [1] 21.2 10.4 [4]
LIFO valuation inventory expense (benefit)   0.0
Non-cash equity compensation [1] 13.9 11.7 [4]
Non-cash asset impairment charge [1],[4],[5]   3.6
Non-cash unrealized loss on derivative positions [1],[4]   2.2
Gain on disposition of property, plant and equipment [1] (9.1) (3.7) [4]
Bad debt expense [1] 0.3 0.3 [4]
Non-cash postretirement and postemployment defined benefit plan cost [1] 7.1 6.8 [4]
Changes in operating assets and liabilities:    
Trade and other receivables [1] (79.7) (33.7) [4]
Contract assets [1] 19.4 (3.5) [4]
Inventories [1] (100.4) (8.0) [4]
Prepaid expenses and other current assets [1] (3.4) (5.6) [4]
Accounts payable [1] 122.3 17.5 [4]
Accrued liabilities [1] (28.3) (11.6) [4]
Annual variable cash contributions to Salaried VEBA [1] (0.7) (1.1) [4]
Long-term assets and liabilities, net [1] (8.2) 3.9 [4]
Net cash provided by operating activities [1] 132.0 123.7 [4]
Cash flows from investing activities:    
Capital expenditures [1] (106.4) (124.8) [4]
Purchase of equity securities [1] (0.4) (0.1) [4]
Proceeds from sale of equity securities [1] 6.4 0.3 [4]
Proceeds from disposition of property, plant and equipment [1] 10.7 6.0 [4]
Net cash used in investing activities [1] (89.7) (118.6) [4]
Cash flows from financing activities:    
Borrowings under the Revolving Credit Facility [1] 290.4  
Repayment of borrowings under the Revolving Credit Facility [1] (290.4)  
Repayment of finance lease [1] (1.8) (2.0) [4]
Cancellation of shares to cover tax withholdings upon common shares issued [1] (2.9) (1.8) [4]
Cash dividends and dividend equivalents paid [1] (38.5) (38.0) [4]
Net cash used in financing activities [1] (43.2) (41.8) [4]
Net decrease in cash, cash equivalents and restricted cash during the period (0.9) (36.7) [4]
Cash, cash equivalents and restricted cash at beginning of period 37.9 100.7 [4]
Cash, cash equivalents and restricted cash at end of period $ 37.0 $ 64.0 [4]
[1] See Note 12 for supplemental cash flow information.
[2] Adjusted to reflect the retrospective change in inventory valuation methodology from LIFO to WAC. See Note 14 for further discussion.
[3] Adjusted to reflect the retrospective change in inventory valuation methodology from LIFO to WAC. See Note 14 for further discussion.
[4] Adjusted to reflect the retrospective change in inventory valuation methodology from LIFO to WAC. See Note 14 for further discussion.
[5] Non-cash asset impairment charge for the nine months ended September 30, 2024 is comprised of: (i) a $3.2 million inventory write-down related to certain alloying metals and (ii) a $0.4 million impairment charge on land held for sale.